Subcutaneous BoNT/A Injection for Intractable Pain and Disability in Complex Regional Pain Syndrome: A Case Report.
CRPS
botulinum toxin
disability
pain
subcutaneous injection
Journal
Toxins
ISSN: 2072-6651
Titre abrégé: Toxins (Basel)
Pays: Switzerland
ID NLM: 101530765
Informations de publication
Date de publication:
16 06 2022
16 06 2022
Historique:
received:
15
05
2022
revised:
01
06
2022
accepted:
14
06
2022
entrez:
23
6
2022
pubmed:
24
6
2022
medline:
28
6
2022
Statut:
epublish
Résumé
We treated a 51-year-old woman with refractory Complex Regional Pain Syndrome type I (CRPS-I) involving her left hand and forearm with subcutaneous injections of BoNT/A. The injections were performed every 3 months, with a total of six treatments. Each treatment was able to effectively improve pain and motor impairment; however, the duration of the effect was limited to only a few months. BoNT/A could improve patients' quality of life with CRPS; however, extensive clinical studies are needed to determine its role in clinical practice.
Identifiants
pubmed: 35737072
pii: toxins14060411
doi: 10.3390/toxins14060411
pmc: PMC9227913
pii:
doi:
Substances chimiques
Neuromuscular Agents
0
Botulinum Toxins, Type A
EC 3.4.24.69
Types de publication
Case Reports
Langues
eng
Sous-ensembles de citation
IM
Références
Pain. 2006 Feb;120(3):235-243
pubmed: 16427737
J Biol Chem. 1992 Oct 25;267(30):21338-43
pubmed: 1356988
Science. 1985 Jan 11;227(4683):184-7
pubmed: 3966152
Traffic. 2007 Feb;8(2):142-53
pubmed: 17241445
Neuropharmacology. 2013 Jul;70:331-7
pubmed: 23499661
J Neurosci. 1997 Oct 15;17(20):8003-8
pubmed: 9315918
Pain Physician. 2011 May-Jun;14(3):311-6
pubmed: 21587336
Bratisl Lek Listy. 2004;105(3):108-16
pubmed: 15253529
Clin J Pain. 2000 Jun;16(2 Suppl):S12-20
pubmed: 10870735
Toxins (Basel). 2018 Apr 19;10(4):
pubmed: 29671801
Pain Med. 2010 Sep;11(9):1415-8
pubmed: 20735753
J Neural Transm (Vienna). 2014 Jun;121(6):665-9
pubmed: 24420081
Neuroscience. 2011 Feb 23;175:358-66
pubmed: 21111791
Am J Ind Med. 1996 Jun;29(6):602-8
pubmed: 8773720
Neurol Neurochir Pol. 2021;55(2):133-140
pubmed: 33797747
Biochem Pharmacol. 2000 Jun 1;59(11):1403-6
pubmed: 10751549
PLoS One. 2012;7(10):e47977
pubmed: 23110146
Toxins (Basel). 2022 Jan 03;14(1):
pubmed: 35051013
Br J Pharmacol. 2016 Jan;173(2):279-91
pubmed: 26493010
Pharmacol Rev. 2017 Apr;69(2):200-235
pubmed: 28356439
J Pain. 2015 Feb;16(2):99-115
pubmed: 25478803
Front Neurol. 2014 Jun 23;5:98
pubmed: 25002857
Pain. 2010 Sep;150(3):439-450
pubmed: 20627413
Clin Neurophysiol. 2008 Aug;119(8):1705-1719
pubmed: 18486546
Handb Clin Neurol. 2015;131:481-503
pubmed: 26563805
Front Cell Infect Microbiol. 2017 Apr 26;7:141
pubmed: 28491822
Toxicon. 2019 Mar 1;159:41-44
pubmed: 30660558
Headache. 2004 Jan;44(1):35-42; discussion 42-3
pubmed: 14979881
Neurosci Lett. 2016 Aug 3;627:216-21
pubmed: 27268041
Eur J Pharmacol. 1989 May 2;164(1):45-53
pubmed: 2568939
Pain Med. 2010 Sep;11(9):1411-4
pubmed: 20609130
Headache. 2010 Jun;50(6):921-36
pubmed: 20487038
Toxicon. 2018 Jun 1;147:120-128
pubmed: 29409817
PM R. 2012 Jun;4(6):446-9
pubmed: 22732156
Neurobiol Dis. 2012 Dec;48(3):367-78
pubmed: 22820141
J Pain Res. 2011;4:347-55
pubmed: 22090803
Pain. 2010 Aug;150(2):268-274
pubmed: 20493633
Pain. 2014 Aug;155(8):1516-1526
pubmed: 24793910
Lancet Neurol. 2015 Feb;14(2):162-73
pubmed: 25575710
Neurobiol Dis. 2015 Jul;79:111-22
pubmed: 25958249
Pain. 2004 Apr;108(3):248-257
pubmed: 15030944
J Pain. 2015 Jun;16(6):518-26
pubmed: 25746196